Condition: Prostate Cancer · Sponsor: University of Lausanne Hospitals
This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-field MRI.
This description comes directly from the study's public registry record.
Naïk Vietti-Violi, Dre · 0795560240 · Naik-Vietti-Violi@chuv.ch
Gorun Ilanjian, Dr · 0795560232 · Gorun.Ilanjian@chuv.ch
Always discuss trial participation with your own doctor first.
| Lausanne University Hospital | Lausanne, Canton of Vaud, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06482489